Genome analysis for pathogens, Biotech, SaaS.
GenPAx has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in March 2022.
GenPAx is headquartered in Gstaad, Switzerland.
Genome analysis for pathogens, Biotech, SaaS.
GenPAx is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GenPAx — Funding & Investors." VCBacked, March 1, 2022, https://www.vcbacked.co/company/genpax. Accessed August 15, 2026.
VCBacked. (2022). GenPAx — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/genpax
{{cite web |title=GenPAx — Funding & Investors |url=https://www.vcbacked.co/company/genpax |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated